In a study published in the Journal of Orthopaedic Research, investigators have identified urinary markers that differentiate total hip replacement patients who eventually develop bone tissue destruction, or osteolysis, from patients who do not. For the study, researchers used a repository of 24-hour urine samples collected prior to surgery and annually thereafter in 26 patients,